Previously our study showed that lung cancer cells impair the differentiation and function of DCs, which is supported by changing phenotype (decreasing CD1a up-regulation and the appearance of CD14) and expression of high levels of IL-10 [20]. This evidence concerns the gene CD1A and lung carcinoma.